Responses
Clinical/translational cancer immunotherapy
Original research
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
Compose a Response to This Article
Other responses
No responses have been published for this article.
